ORTHOPEDIC REGENERATIVE MEDICINE MARKET ANALYSIS

Regional Analysis

Global Orthopedic Regenerative Medicine Market - Regional Analysis

Among region, North America is estimated to hold a dominant position in the global orthopedic regenerative medicine market over the forecast period. The global orthopedic regenerative medicine market is expected to witness significant growth in the near future due to rising adoption of inorganic growth strategies such as acquisition by key players in the market. For instance, on June 27, 2023, Alpha Healthcare Acquisition Corp., a medical device company, announced the acquisition of Carmell Therapeutics Corporation, a phase 2 stage regenerative medicine platform company developing allogeneic plasma-based biomaterials for active soft tissue repair, aesthetics, and orthopedic indications.

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa